Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Basel

Discovery & Development Europe 2025

Be part of the renowned Discovery & Development Summit in Basel, uniting 1000+ leaders in biology and chemistry to connect, collaborate, and accelerate the development [...]

Basel

SGPP Annual Congress/PSY Congress 2025

"Psyche, Human, Brain – Psychiatry at the Center" forms the central theme of the 2025 edition. The program promises insightful keynote speeches and state-of-the-art presentations [...]

Basel

Tides Europe 2025

The TIDES Europe conference agenda is designed with scientific tracks that delve into comprehensive discovery, development, and manufacturing strategies. These sessions will explore emerging trends [...]

Go to Top